이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Effectiveness of Online Gut-Directed Hypnotherapy and Movement Motivational and Self-management Training for Abdominal Pain Disorders in Adolescents (HIPMO)

2026년 11월 12일 업데이트: János Major, Bethesda Children's Hospital

Effectiveness of Online Hypnotherapy and Movement Motivation Training for Abdominal Pain Disorders in Adolescents

The present study is an online-based investigation involving adolescents with abdominal pain disorders, defined as recurrent abdominal pain persisting for at least two months. The study aims to evaluate the feasibility, acceptability, and effectiveness of online therapeutic interventions in comparison with usual pediatric gastroenterological care.

The study has two primary objectives. The first is to make two therapeutic interventions-Movement Motivation and Self-management Training (M3 Training) and gut-directed hypnotherapy-available online in Hungarian to young people with abdominal pain disorders and their families. Providing these interventions in an online format may facilitate easier and more timely access to therapeutic support for adolescents experiencing abdominal symptoms.

The second objective is to evaluate the effectiveness of the two online interventions. Specifically, the effectiveness of M3 Training and gut-directed hypnotherapy will be assessed both as individual interventions and in combination, and compared with usual pediatric gastroenterological care. This evaluation will assess whether the online interventions, delivered individually or in combination, offer effective therapeutic options for adolescents with abdominal pain disorders, focusing on both primary and secondary outcomes.

연구 개요

상태

아직 모집하지 않음

정황

연구 유형

중재적

등록 (추정된)

800

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

    • Budapest
      • Budapest, Budapest, 헝가리, 1146
        • HRC Bethesda Children's Hospital
        • 부수사관:
          • Katalin Forgács-Kristóf, MSc
        • 연락하다:
        • 부수사관:
          • Adrienn Vargay, PhD
        • 부수사관:
          • Sára Bencsik, MD
        • 부수사관:
          • Nándor Hajdú, PhD
        • 부수사관:
          • Katalin Eszter Müller, MD, PhD

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

12년 (어린이, 성인)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

Following the minimum diagnostic work-up performed by a gastroenterologist, including:

  • celiac disease serology;
  • C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR);
  • complete blood count (CBC);
  • total protein;
  • albumin;
  • aspartate aminotransferase (AST; GOT);
  • alanine aminotransferase (ALT; GPT);
  • gamma-glutamyl transferase (GGT);
  • lactate dehydrogenase (LDH);
  • alkaline phosphatase (ALP);
  • urea;
  • creatinine;
  • iron studies;
  • urinalysis, at minimum using a urine dipstick;
  • fecal calprotectin or fecal occult blood testing.

Participants will be included in the study based on symptoms consistent with abdominal pain disorders according to the Rome V criteria and the following inclusion criteria:

  • Continuous or regularly recurrent abdominal pain persisting for at least 3 months.
  • No identifiable underlying organic disease that could explain the abdominal pain.
  • Able to care for themselves, capable of self-care and able to understand and follow the study procedures.
  • Able to read and write in Hungarian.
  • Has access to the internet.

Exclusion Criteria:

  • Known severe psychiatric disorder
  • Epilepsy
  • Gastrointestinal disease requiring treatment and associated with pain symptoms
  • Proctalgia fugax
  • Intellectual disability.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 삼루타

무기와 개입

참가자 그룹 / 팔
개입 / 치료
간섭 없음: Standard care

In the standard care control group, as in the intervention groups, participants will use an online platform (hasifajdalomkezeles.hu) to record their adherence to the treatment recommended by their gastroenterologist. The website does not include any therapeutic videos or active intervention. Its sole function is to support repeated online questionnaire-based data collection assessing treatment fidelity, adherence, and perceived effectiveness of the treatment.

The primary and secondary outcome questionnaires become available at predefined time points over a 12-week period.

실험적: Gut-Focused Hypnosis Program

The hypnosis arm is delivered through the same main study website (hasifajdalomkezeles.hu), presenting content developed based on the Dutch model of gut-directed hypnosis (www.hypnosis4abdominalpain.com), adapted with permission to Hungarian. The program is primarily based on video and audio materials and follows a predefined, standardised structure.

The 12-week-long intervention content has a linear format consisting of sequential modules that introduce: the concept of abdominal pain disorders; the development of bowel hypersensitivity; the principles of medical hypnosis; and the role of hypnosis in the treatment of abdominal pain.

This section is accompanied by weekly audio-based exercises that are designed to align with the original Dutch model. Adolescents are encouraged to complete the exercises that correspond to the weekly audio sessions, promoting deeper engagement and understanding of the material.

The hypnosis website is non-adaptive and non-personalised.

The hypnosis arm is delivered through the same main study website (hasifajdalomkezeles.hu), presenting content developed based on the Dutch model of gut-directed hypnosis ( www.hypnosis4abdominalpain.com), adapted with permission to Hungarian. The program is primarily based on video and audio materials and follows a predefined, standardised structure.

The 12-week-long intervention content has a linear format consisting of sequential modules that introduce: the concept of abdominal pain disorders; the development of bowel hypersensitivity; the principles of medical hypnosis; and the role of hypnosis in the treatment of abdominal pain.

This section is accompanied by weekly audio-based exercises that are designed to align with the original Dutch model. Adolescents are encouraged to complete the exercises that correspond to the weekly audio sessions, promoting deeper engagement and understanding of the material.

The hypnosis website is non-adaptive and non-personalised.

실험적: M3 Training

M3 Training is a fully digitalised, 12-week online movement-motivation program delivered through the same website (hasifajdalomkezeles.hu). The previously developed and tested M3 Training program is fully adapted for digital delivery, with content specifically designed to support young people with chronic abdominal pain in developing their own movement program.

During the first two weeks, the video series guides participants through the process of designing an individually developed movement program, which they then carry out over 3 months. From weeks 3 to 12, participants receive ongoing motivational videos and supporting materials aimed at maintaining engagement and supporting implementation of their movement plan. Throughout this period, participants are able to modify and further develop their movement program.

Participants provide written responses to questions linked to the videos through the website, allowing them to reflect on their experiences and development throughout.

M3 Training is a fully digitalised, 12-week online movement-motivation program delivered through the same website (fasifajdalomkezeles.hu). The previously developed and tested M3 Training program is fully adapted for digital delivery, with content specifically designed to support young people with chronic abdominal pain in developing their own movement program.

During the first two weeks, the video series guides participants through the process of designing an individually developed movement program, which they then carry out over 3 months. From weeks 3 to 12, participants receive ongoing motivational videos and supporting materials aimed at maintaining engagement and supporting implementation of their movement plan. Throughout this period, participants are able to modify and further develop their movement program.

Participants provide written responses to questions linked to the videos through the website, allowing them to reflect on their experiences and development throughout.

실험적: Combined Hypnosis + M3 Training

This arm represents an integrated version of the hypnosis program and M3 Training, combining the two existing interventions into a single 12-week online program. Users access both therapeutic components through the same website (hasifajdalomkezeles.hu). During the 12-week-long joint program the hypnosis-related content and the M3 Training videos are released according to a coordinated schedule. The aim is not simply to provide the two interventions in parallel, but to achieve structured integration, ensuring that the two approaches complement one another.

The hypnosis arm is delivered through the same main study website (hasifajdalomkezeles.hu), presenting content developed based on the Dutch model of gut-directed hypnosis ( www.hypnosis4abdominalpain.com), adapted with permission to Hungarian. The program is primarily based on video and audio materials and follows a predefined, standardised structure.

The 12-week-long intervention content has a linear format consisting of sequential modules that introduce: the concept of abdominal pain disorders; the development of bowel hypersensitivity; the principles of medical hypnosis; and the role of hypnosis in the treatment of abdominal pain.

This section is accompanied by weekly audio-based exercises that are designed to align with the original Dutch model. Adolescents are encouraged to complete the exercises that correspond to the weekly audio sessions, promoting deeper engagement and understanding of the material.

The hypnosis website is non-adaptive and non-personalised.

M3 Training is a fully digitalised, 12-week online movement-motivation program delivered through the same website (fasifajdalomkezeles.hu). The previously developed and tested M3 Training program is fully adapted for digital delivery, with content specifically designed to support young people with chronic abdominal pain in developing their own movement program.

During the first two weeks, the video series guides participants through the process of designing an individually developed movement program, which they then carry out over 3 months. From weeks 3 to 12, participants receive ongoing motivational videos and supporting materials aimed at maintaining engagement and supporting implementation of their movement plan. Throughout this period, participants are able to modify and further develop their movement program.

Participants provide written responses to questions linked to the videos through the website, allowing them to reflect on their experiences and development throughout.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Pain intensity (proportion of patients with ≥30% improvement in abdominal pain) measured by Numerical Rating Scale
기간: From enrollment to the end of treatment at 12 weeks.

≥30% reduction in pain intensity is our main outcome. Pain intensity will be assessed using an 11-point Numerical Rating Scale (NRS; 0-10), which is a validated measure of self-reported pain intensity in children and adolescents (Miró et al., 2009).

From enrollment to the end of treatment at 12 weeks.
Quality of Life measured by The Pediatric Quality of Life Inventory
기간: From enrollment to the end of treatment at 12 weeks

The Pediatric Quality of Life Inventory (PedsQL) is a validated questionnaire designed to assess health-related quality of life in children and adolescents.

From enrollment to the end of treatment at 12 weeks

2차 결과 측정

결과 측정
측정값 설명
기간
Functional Disability assessed by Functional Disability Inventory
기간: From enrollment to the end of treatment at 12 weeks

The Functional Disability Inventory (FDI) is a 15-item self-report measure assessing limitations in everyday physical, social, and school-related activities. It has been extensively validated in children and adolescents, including a large sample of 596 patients aged 8-17 years with chronic abdominal pain (Walker & Greene, 1991; Claar & Walker, 2006). Both the child and parent versions of the questionnaire will be administered.

From enrollment to the end of treatment at 12 weeks
Anxiety and Depression measured by Revised Children's Anxiety and Depression Scale (RCADS)
기간: From enrollment to the end of treatment at 12 weeks

The Revised Children's Anxiety and Depression Scale (RCADS) is a 47-item self-report questionnaire assessing symptoms of anxiety and depression in children and adolescents and has demonstrated good psychometric properties in both community and clinical populations (Chorpita et al., 2000; Chorpita et al., 2005). Both the child and parent versions of the questionnaire will be administered.

From enrollment to the end of treatment at 12 weeks
Gastrointestinal symptom-specific anxiety measured by Visceral Sensitivity Index
기간: From enrollment to the end of treatment at 12 weeks

The original Visceral Sensitivity Index (VSI) is a 15-item, unidimensional self-report questionnaire developed to assess gastrointestinal symptom-specific anxiety-that is, anxiety, worry, and fear related to gastrointestinal sensations, symptoms, and the situations in which these symptoms may occur. It was developed and validated in 96 adult patients with irritable bowel syndrome (IBS) and showed excellent reliability together with good content, convergent, divergent, and predictive validity (Labus et al., 2004). Both the child and parent versions of the questionnaire will be administered.

From enrollment to the end of treatment at 12 weeks
Different cognitive, behavioural, and interpersonal strategies used by children to cope with pain assessed by Pain Coping Questionnaire
기간: From enrollment to the end of treatment at 12 weeks

The Pain Coping Questionnaire (PCQ) is a 39-item self-report measure assessing different cognitive, behavioural, and interpersonal strategies used by children to cope with pain. It was developed for children and adolescents and has been validated from approximately 8 years of age, including populations with recurrent pain (Reid et al., 1998). Both the child and parent versions of the questionnaire will be administered.

From enrollment to the end of treatment at 12 weeks
Missing school days collected from parents
기간: From enrollment to the end of treatment at 12 weeks

School absence will be assessed as the parent-reported number of school days missed because of abdominal pain or gastrointestinal symptoms during a predefined recall period. Both the child and parent versions of the questionnaire will be administered.

From enrollment to the end of treatment at 12 weeks
Sleep characteristics assessed using study-specific self-report items
기간: From enrollment to the end of treatment at 12 weeks

Sleep characteristics will be assessed using study-specific self-report items covering perceived sleep quality, average nightly sleep duration, and frequency of daytime naps.

From enrollment to the end of treatment at 12 weeks
Intervention Satisfaction and Patient Global Impression of Change assessed by open-ended question
기간: From enrollment to the end of treatment at 12 weeks

Patient satisfaction will be explored using the following open-ended question: "What story would you tell your best friend about your experience with the therapy over the past 12 weeks?"

Patient Global Impression of Change will be measured through the following question:

Since the start of the study, my overall status is: options range from "Very Much Improved" to "Very Much Worse" Both the child and parent versions of the questionnaire will be administered.

From enrollment to the end of treatment at 12 weeks
Website engagement collected via webpage
기간: From enrollment to the end of treatment at 12 weeks

Website monitoring will include the number and timing of logins, the duration and frequency of listening to the audio recordings, the duration and frequency of viewing the M3 videos, whether each audio recording was listened to at least once, whether each video was viewed at least once, and whether all questions were answered; if not, the number and identity of unanswered questions will also be recorded.

From enrollment to the end of treatment at 12 weeks
Adequate Relief of Abdominal Pain and/or Discomfort assessed using a single dichotomous (yes/no) question.
기간: From enrollment to the end of treatment at 12 weeks

Proportion of participants reporting adequate relief of abdominal pain and/or discomfort during the preceding week compared with baseline, assessed using a single dichotomous (yes/no) question.

From enrollment to the end of treatment at 12 weeks

기타 결과 측정

결과 측정
측정값 설명
기간
Adverse event assessed by open-ended questions
기간: From enrollment to the end of treatment at 12 weeks

Adverse events will be monitored prospectively throughout the intervention period. An adverse event will be defined as any new or worsening unfavourable physical or psychological health-related occurrence during study participation, irrespective of whether it is considered to be related to the intervention. At each scheduled assessment, participants will be asked about any new or worsening health-related problems since the previous assessment. If an adverse event is reported, a brief description of the event, its impact on daily activities, whether medical attention was required, and whether it resulted in modification or discontinuation of the intervention will be recorded. Reported events will subsequently be reviewed by the study team with respect to severity, seriousness, expectedness, and possible relatedness to the intervention (Junqueira et al., 2023; Burns et al., 2024). Both the child and parent versions of the questionnaire will be administered.

From enrollment to the end of treatment at 12 weeks

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

유용한 링크

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 12월 1일

기본 완료 (추정된)

2030년 12월 1일

연구 완료 (추정된)

2030년 12월 1일

연구 등록 날짜

최초 제출

2026년 11월 12일

QC 기준을 충족하는 최초 제출

2026년 11월 12일

처음 게시됨 (실제)

2026년 11월 18일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 18일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 12일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

추가 관련 MeSH 약관

기타 연구 ID 번호

  • BM/9151-1/2024

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다